2nd Asia-Pacific Neuro-Oncology CME Conference is organized by Harvard Medical School (HMS) and will be held from Aug 03 - 07, 2020 at Sheraton Maui Resort & Spa, Lahaina, Hawaii, United States of America.
This course is targeted to health care specialists involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists).
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Harvard Medical School designates this live activity for a maximum of 24.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 1.00 hour of Risk Management Study. This includes 1.00 credit of End-of-Life Care Studies. Please check your individual state licensing board requirements before claiming these credits.
Neuro-oncology is a rapidly evolving multi-disciplinary field, which involves the medical, surgical and radiation management of adult and pediatric patients with primary and metastatic brain and spinal cord tumors. In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This five-day CME course, the Asia-Pacific Neuro-Oncology CME Conference, is designed to provide an international audience with a comprehensive review of the diagnosis and management of adult and pediatric patients with primary and metastatic brain and spinal cord tumors and neurologic complications of cancer.
Upon completion of this activity, participants will be able to:
• Evaluate, diagnose and treat adult and pediatric patients with primary and metastatic central nervous system tumors
• Appreciate the role of biomarkers in the diagnosis and treatment of brain and spinal cord tumors
• Recognize and address neurological complications associated with cancer and new cancer therapies
• Discuss the role of palliative and supportive care in neuro-oncology
Conference Fee Details
|Early Fee Last date||:||NA|
Plan Your Travel
Reviews Given by People
Subscribe to our Newsletterx
Subscribe to our newsletter and receive updates on medical conferences, board review courses and news